Rob Dillard

DocwireNews

<h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/the-role-of-intensive-cardiac-rehabilitation-in-resistant-hypertension-an-uncharted-territory/">The Role of Intensive Cardiac Rehabilitation in Resistant Hypertension: An Uncharted Territory</a><p>A structured 4-month diet and cardiac rehabilitation program in addition to medications lead to a significant reduction in blood pressure (BP) in patients with resistant hypertension, according to<a href="https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055329"> the TRIUMPH trial</a> recently published in <em>Circulation</em>. &ldquo;Resistant hypertension represents a big problem,&rdquo; comments <a href="https://twitter.com/cingolani_oscar">Dr. Oscar Cingolani</a>, director of the Hypertension Center at the Johns Hopkins Hospital. &ldquo;There are several studies showing that the degree of compliance with antihypertensive medications is inversely correlated with the number of drugs taken. On the other hand, lowering as little as 3-5 mm Hg in systolic BP can lower cardiovascular risks significantly. The TRIUMPH study showed us that a dedicated lifestyle intervention in resistant hypertension can result in BP drop equivalent to what we often see by adding one to two extra medications (provided patients take them).</p><h2><a href="https://www.docwirenews.com/cardiology/another-study-suggests-too-much-fish-oil-could-trigger-a-fib/">Another Study Suggests Too Much Fish Oil Could Trigger A-Fib</a></h2><p>While most of the people prefer <a href="https://resurgencebehavioralhealth.com/blog/holistic-alcohol-and-drug-rehab/">alternative drug rehab in LA</a> to get rid off drug addiction.A new study from the <a href="https://qtreatment.com/">Quantum drug and alcohol in new jersey</a> rehab confirms that fish oil supplements may raise the risk of a common heart-rhythm disorder &mdash; particularly when doses top 1 gram per day. The analysis &mdash; published recently in the journal <em><a class="rm-stats-tracked" href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055654" target="_blank" rel="noopener noreferrer">Circulation</a></em>&nbsp;&mdash; involved over 81,000 patients in total. During the study period, 3.6% developed a-fib.</p><p>Overall, Albert and her team found, trial participants given omega-3 were more likely to develop a-fib over an average of five years, versus those given a placebo.</p><h2><a href="https://www.docwirenews.com/pad-knowledge-hub/pad-knowledge-hub-picks/cad-risk-up-with-radiation-treatment-for-left-sided-breast-cancer/">CAD Risk Up With Radiation Treatment for Left-Sided Breast Cancer</a></h2><p>Young women treated with radiation therapy (RT) for left-sided breast cancer have an increased risk for coronary artery disease (CAD) compared with those treated for right-sided breast cancer, according to a study published in the Sept. 1 issue of <em>JACC: CardioOncology</em>.</p><p>Lauren E. Carlson, M.P.H., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues reported CAD risk among 1,583 women aged younger than 55 years when diagnosed with breast cancer between 1985 and 2008. The risk for radiation-associated CAD was assessed by comparing women treated with left- versus right-sided RT. Overall, 972 women were eligible for analyses and were followed for a median of 14 years.</p><p>The researchers found that the 27.5-year cumulative incidences of CAD were 10.5 and 5.8 percent for women receiving left- versus right-sided RT, respectively. In the multivariable Cox model, the corresponding hazard ratio for CAD was 2.5 for left- versus right-sided RT. No statistically significant effect modification was seen by any factor evaluated.</p><h2><a href="https://www.docwirenews.com/docwire-pick/cardiology-picks/study-shows-positive-effect-of-with-xarelto-rivaroxaban-compared-to-aspirin-in-pediatric-fontan-procedure-patients-at-risk-for-blood-clots/">Rivaroxaban Shows Promise For Pediatric Fontan Procedure Patients at Risk for Blood Clots</a></h2><p>The Jansen Pharmaceutical Companies of Johnson &amp; Johnson recently announced new data from the Phase III UNIVERSE study which demonstrated treatment with rivaroxaban in an oral suspension formulation, compared to treatment with aspirin, was associated with blood clots in pediatric patients who have undergone the Fontan procedure.</p><p>The Fontan procedure is performed in children with congenital heart disease who have a single functioning ventricle to redirect blood flow to the lungs to be reoxygenated. Children who undergo the Fontan procedure often face significant morbidity and mortality stemming from thrombotic events, especially during the critical 3- to 12-month period following the procedure. While it is common for physicians to prescribe aspirin, there are limited data regarding aspirin resistance or the optimal dose for thromboprophylaxis in children.</p><p>&ldquo;For years, health care providers have had limited options to help reduce potentially fatal thrombotic events that often occur in young children following the Fontan procedure,&rdquo; said&nbsp;<span class="xn-person">Brian W. McCrindle</span>, M.D., MPH, Pediatric Cardiologist at the Hospital for Sick Children in&nbsp;<span class="xn-location">Toronto via a <a href="https://www.prnewswire.com/news-releases/new-phase-3-data-suggest-positive-effect-and-show-similar-safety-with-xarelto-rivaroxaban-compared-to-aspirin-in-pediatric-fontan-procedure-patients-at-risk-for-blood-clots-and-blood-clot-related-events-301385198.html">press release</a>.</span>&nbsp; &ldquo;We now not only have data suggesting that rivaroxaban has a similar positive effect and safety as aspirin, but we also have identified an age-appropriate formulation with precise weight-based dosing to help manage our young patients during a critical time.&rdquo;</p><p>&nbsp;</p></h2>


Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

HER2 Breast Cancer

Trodelvy Plus Keytruda Significantly Improves Progression-Free Survival in PD-L1+ mTNBC, Phase III Data Show

Triple-Negative Breast Cancer

Jordana Jampel

Actress Michelle Trachtenberg's Premature Death From Diabetes Reveals Dangers of Chronic Complications

Diabetes

Latest News

Cardio Round-Up: The Role of Intensive Cardiac Rehab in Resistant Hypertension; and More

Cardiology

The Role of Intensive Cardiac Rehabilitation in Resistant Hypertension: An Uncharted Territory ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe